Boston Scientific says will be opportunistic with M&A

theflyonthewall.com

Says its two preferred uses of cash are returning cash to shareholders via buybacks, targeted M&A. Says will always be opportunistic with M&A, says always looking to return cash to shareholders. Committed to operating income, EPS growth. Feels "comfortable" with tax rate guidance.

View Comments (0)